Aggressive reperfusion therapy for myocardial infarction (MI) characterized by acute ST-segment elevation leads to improved patient outcome. Furthermore, use of thrombolytic therapy is highly time-dependent: reperfusion therapy is beneficial within 12 h, but the earlier it is administered, the more beneficial it is. Thus, the focus of both prehospital and emergency department management of patients with acute MI is on rapid identification and treatment. There are many components to the time delays between the onset of symptoms of acute MI and the achievement of reperfusion in the occluded infarct-related artery. Time delays occur with both the patient and the prehospital emergency medical system, although patient delays are more significant. This article focuses on the prehospital management of acute MI, including (1) the rationale for rapid reperfusion in patients with acute MI, (2) the factors related to time delays in patient presentation to the hospital, and (3) strategies for reducing time delays, both patient-and medical system-based.
There are many components to the time delays between the patient's onset of symptoms of acute myocardial infarction (MI) and the achievement of reperfusion in the occluded infarct-related artery (Fig. 1 ). 1 The early open artery theory is the paradigm in which thrombolytic therapy is understood to be beneficial in patients with acute MI: early achievement of an open infarct-related artery is associated with improved patient outcome. 2 Animal studies, 3 initial angiographic studies in patients using intracoronary streptokinase, 4, 5 and numerous other angiographic studies over the subsequent 15 years [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] have all lent strong support to this theory. An overview of angiographic studies in over 4,200 patients demonstrated that patients with a patent infarct-related artery 90 min after treatment with thrombolysis had a 50% lower mortality rate compared with patients who had a persistently occluded artery (p < 0.00001). 17 Furthermore, patients who achieved thrombolysis in myocardial infarction (TIMI) grade 3 flow (defined as a patent artery with normal flow) 18 at 90 min had a 66% lower mortality rate than patients who had an occluded artery (p < 0.00001). 17 Thus, the modern management of acute MI appropriately focuses on rapid achievement of reperfusion of the infarct-related artery.
Importance of Time to Treatment
Achievement of early infarct-related artery patency is the cornerstone of acute MI management. One method of achieving an open artery early is to begin thrombolytic therapy as quickly as possible after onset of symptoms. As such, time can be considered an "adjunctive agent" in a thrombolytic or reperfusion regimen. 1 The importance of time to treatment was highlighted initially by the first megatrial, Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI-1), which found that streptokinase led to a 19% reduction in mortality compared with placebo. However, patients who were treated within 1 h of the onset of chest pain had a 50% reduction in mortality. 19 The TIMI-2 trial extended these observations and found that for each hour earlier that a patient was treated, the absolute mortality rate decreased by 1%, 20 which translates into an additional 10 lives saved per 1,000 patients treated ( Fig. 2A) . 17 This has also been observed in the Global Use of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO)-I trial (Fig. 2B) 21, 22 and in an initial series of patients treated with primary percutaneous transluminal coronary angioplasty. 23 The mechanism of benefit of rapid time to treatment fits the paradigm of the early open artery theory. Rapid time to treatment has been shown to be associated with reduced infarct size Clin. Cardiol. 22, (Suppl. IV), IV-10-IV- 19 (1999) ( Fig. 3) and improved left ventricular function. 24, 25 Thus, earlier treatment with either thrombolysis or primary angioplasty is associated with improved survival, emphasizing the need to speed treatment. 26 With this goal in mind, rapid identification and transportation of the patient with MI to the hospital have been the main focus of prehospital management of patients with MI. Some variables that affect thrombolysis treatment when the patient is in the emergency department appear in Table I .
National Heart Attack Alert Program
In recognition of the need to expand the use of known therapies for acute MI, such as thrombolysis and early defibrillation, the National Heart, Lung, and Blood Institute (NHLBI) launched the National Heart Attack Alert Program (NHAAP) in June 1991. The NHAAP is a national education effort to promote the rapid identification and treatment of acute MI, with the overriding goal of reducing mortality and morbidity from acute MI, including sudden death. The NHAAP has divided the aspects of acute MI management into three phases, which provide a basis for improving care in the prehospital and hospital phases of management (Fig. 4) . 27 Phase I consists of the patient component of time delay. The NHAAP has several initiatives in this area. First, NHAAP personnel helped sponsor the Rapid Early Access to Coronary Treatment (REACT) trial of public education and also made a recommendation for patient/bystander recognition and action, that is, that the patient must recognize the symptoms and signs of a possible heart attack and seek help immediately. 28, 29 Phase II is the prehospital action component: emergency medical services (EMS) staff should be dispatched appropriately and respond, evaluate, and transport the patient in the shortest time possible, while providing needed life-sustaining measures. [30] [31] [32] [33] Phase III is the hospital action component: the emergency department staff of the hospital receives the patient and must be prepared to diagnose acute MI rapidly 34 and promptly initiate reperfusion (and other) therapy as appropriate. 35 The final component is reperfusion therapy, that is, the time from initiation of thrombolytic therapy to actual achievement of reperfusion. 1
Patient Delays
Studies of treatment delay indicate that the most common reason for delay is the patient not seeking care promptly. 36 The median delay in seeking care after the onset of symptoms of acute MI ranges from 2 to 6.4 h. 37 In the prethrombolytic era, an overview of 16 studies noted that the median delay was approximately 3 h. 38 The median delay to thrombolytic treatment in the National Registry of Myocardial Infarction was 2.2 h, although presentation > 6 h after symptom onset was the most common reason for not treating the patient with thrombolytic therapy. 36 In the TIMI-9 Registry of patients with MI characterized by ST-segment elevation, 12% of patients could not be treated with thrombolytics because of presentation > 12 h after the onset of symptoms. 39 Conversely, very few patients are treated within the first hour of onset of symptoms: only 3% of patients in the GUSTO-I trial, 40 3% of patients in the TIMI-2 trial, 41 and 11% of patients in the GISSI-I trial 19 were treated within the first hour of symptom onset. Table II shows the various demographic and clinical factors related to increased and decreased time to patient presentation. 42 Women [43] [44] [45] [46] and older patients 43, [47] [48] [49] tend to exhibit greater delay in presenting to the hospital with acute MI. Only preliminary information is available at present, but delays appear to be considerably greater in patients who are AfricanAmerican 46, 50, 51 (up to 11.9 h in one urban study 50 ). In some studies, low socioeconomic status is associated with an increased delay. 52 Several clinical characteristics also affect patient delay. Severe chest pain is associated with reduced delay but only if it is sudden in onset 46 or accompanied by hemodynamic instability. 43, 48 Patients with a history of angina or diabetes are more likely to delay than patients without these conditions. 43, 44 It is amazing that patients already diagnosed with coronary artery disease, heart failure, or prior MI have the same or greater delay times as those without prior coronary disease. 37, 47 Other healthcare system factors also play a role. If the patient calls a physician, delay is significantly increased. 46, 53 Such delays may increase as health management organizations increasingly insist that patients contact their primary care physician prior to presenting to the emergency department. On the other hand, if the patient consults a friend, co-worker, or stranger, he/she presents to the emergency department more quickly than if consulting a family member/significant oth- 42, 46 possibly because family members or significant others are more easily dissuaded by the patient from calling 9-1-1. 46 Many aspects of these delays have the potential to be modified, and it is hoped that they will translate into improved patient outcomes (see below).
Demographic Factors

Transport/Emergency Medical Service-Related Factors
The transport of the patient by ambulance or private vehicle adds only an average of 7 to 22 min to the delay time. In rural areas, much longer delays are common. 54, 55 However, use of 9-1-1 to access EMS has been shown to decrease the time to reperfusion with thrombolytic therapy by as much as 60 min for individuals with symptoms and signs of an acute MI compared with patients who transport themselves. 24 Patients who arrive by EMS are transported rapidly, bypass emergency department triage, have had vital signs, history, physical examination, and intravenous lines done in the field. In addition, the hospital is commonly notified of their condition prior to arrival and they are, in general, taken more seriously by the emergency department staff than are patients presenting by private transportation. Unfortunately, only half of patients with symptoms of a heart attack use the EMS system. 56 In addition, as of 1995, EMS was only available in 83% of the United States. 30 Furthermore, poor coordination between EMS and other first-response groups (e.g., fire rescue squads) in some communities may lead to inadvertent delays, which emphasizes the need for community planning in EMS to eliminate such delays.
Improving Time to Treatment and Survival
Reducing Patient Delays
Public awareness: The first component of reducing time delays is improving patient awareness of the symptoms of acute MI. Two approaches can be taken: (1) education of the general public (particularly people at risk for, but without, prior coronary artery disease); and (2) education of patients with stable coronary artery disease, that is, those at highest risk for a subsequent MI, who comprise a much smaller group of patients.
Public awareness campaigns aimed at encouraging patients who are experiencing chest pains or cardiac symptoms to seek medical advice promptly appear to improve the time between onset of symptoms and presentation to a medical facility. 57, 58 A public campaign in the Geneva, Switzerland, area led to a significant reduction in the median time from onset of pain to hospital arrival, although this reduction was only 25 min (p < 0.001). 57 The mean time was reduced by approximately 2.5 h (p < 0.001). 57 Of note, however, was an early transient increase in the number of patients presenting to the hospital with noncardiac chest pain. Another study also found that the median time delay was reduced by approximately 40 min, from 3 h to 2 h and 20 min, during a public media campaign (p < 0.001). 58 These investigators also documented a reduction in infarct size as measured by maximum creatine phosphokinase levels. 58 Thus, based on these initial studies, public campaigns appear to be beneficial in reducing the time it takes a patient to seek treatment.
Because limited information is available about the most effective types of messages to be used for a public campaign and their overall impact, the NHAAP sponsored the randomized trial REACT. Preliminary findings showed that a broad campaign increased the number of patients with acute MI who called 9-1-1 to access the hospital, but there was no overall decrease in time to treatment. It should be noted, however, that different strategies may work in different communitiesthat is, a public campaign in New York City might take a very different approach than one in a rural area. Given the intuitive benefits of public awareness, many hospitals are currently "reaching out" with public service messages about heart attack awareness.
Patient education: The other approach to reducing patient delays during the acute MI phase is to focus the resources and educational materials on patients with coronary artery disease, a much smaller number compared with the general public. Patients with stable coronary artery disease or other significant risk factors for acute MI (e.g., peripheral vascular disease, diabetes, etc.) who are appropriately educated may present earlier to the hospital and have better outcomes. The NHAAP recommends that in both inpatient and outpatient settings, primary care physicians (and specialists) provide patients and their family members with advice about what actions to take in response to the symptoms of an acute MI (or unstable angina). 29 , 42 The discussion should include the emotional aspects (e.g., fear and denial) that patients and those around them may experience in the acute MI setting, as well as barriers that may be associated with the healthcare delivery system (such as distance to the hospital or cost issues). 42 Assistance from other healthcare providers, nurses, for example, should be solicited to initiate, reinforce, and supplement the counseling.
Physicians' offices and clinics should devise a system to triage patients rapidly when they call or walk in seeking advice for possible symptoms of acute MI. 29, 42 This rapid response system should be able to activate EMS by calling 9-1-1 and/or notify the emergency department of an incoming patient with MI symptoms. They need to discourage patients from driving to the emergency department. Further research is needed to learn more about effective counseling strategies, symptom manifestation in high-risk groups (these include women and minorities), and healthcare delivery systems that enhance access to timely care for patients with acute MI. 28 Another practical issue is education of family members. Since family members can frequently be dissuaded by the patient from calling 9-1-1, 46 it is important to educate spouses and other family members about the signs and symptoms of acute MI and to emphasize that they carry out the action plan developed. This can be done in a physician's office during regular follow-up visits for patients with stable coronary artery disease.
Reducing transport and EMS delays: The next component of reducing time delays is focused on reducing transportation time. Amazingly, only 50% of patients with acute MI present to the emergency department by ambulance. 56 Since patients not transported by EMS do not have the benefit of cardiac monitoring and defibrillation in case of lethal arrhythmia, such patients do not receive optimal care. In addition, use of the 9-1-1 EMS system has been shown to reduce time to treatment with thrombolysis, 59 and an ongoing goal is to make 9-1-1 service available throughout the United States. 30 One of the most important focuses of reducing delays and providing care is EMS dispatcher education and certification. 32 These dispatchers need to have the skills to identify patients at risk for MI over the phone, dispatch a crew with appropriate training and equipment to care for the patient, provide the crew with precise directions to the patient's location, and provide the patient/caller with pre-EMS arrival instructions, including when and how to perform cardiopulmonary resuscitation.
The next components of reducing time delays are improving response times for EMS, which has been a continuing priority in the United States and elsewhere, and developing symptom-specific protocols and treatment standing orders. These will allow EMS personnel to start the evaluation and treatment processes while contacting the hospital and communicating with an on-line physician. In addition, improved dialogue and communication between emergency medical technicians and hospital emergency departments have speeded the time to evaluation and treatment in many hospitals. 59 The NHAAP has made recommendations for improving prehospital systems and the preparation of EMS personnel. [30] [31] [32] 
Community Planning
Taking a broader view that encompasses more than just EMS, it must be recalled that there are numerous providers of prehospital care and new concerns regarding where patients should be sent. Fire rescue vehicles provide a large proportion of prehospital care throughout the country, even where EMS are fully developed. Thus, in 1980, the American Heart Association proposed that the entire community be considered a coronary care unit. 60 The rationale for this is that because heart attacks occur at home, at work, and in the community, and people die without potentially lifesaving care, identification and treatment of acute MI (and sudden death in particular, as well as acute coronary syndromes in general) should be community concerns. Therefore, it is critical that communities develop an action plan to ensure a consistent, appropriate, and coordinated response to the needs of patients who will be accessing their community's coronary care system and to educate patients and the public about the need for early and appropriate treatment.
In addition, with the changes in healthcare insurance and preferred providers, some groups are proposing modifications in the longstanding policy that patients with acute MI be transported to the nearest hospital. Transport of very high risk patients with acute MI (e.g., those with cardiogenic shock or contraindications to thrombolysis) to a tertiary care facility with angioplasty capabilities does appear to be medically sound in systems where such facilities are available within a reasonable transport time. However, the criteria and action plan for such a policy need to be developed. The NHAAP has made recommendations on the essential components of a community plan to ensure a seamless response to the patient with acute cardiac symptoms that is the same as at the emergency department/hospital level. 33 The similarities to regionalization of trauma care and categorization of hospital trauma care capabilities are readily apparent. Under these circumstances, patients are treated during transport. Early notification will enable the receiving hospital to prepare for the patient's early reperfusion and lead to a shorter door-to-reperfusion time (and compensate for the longer transport time).
Prehospital Electrocardiograms
Prehospital electrocardiograms (ECGs) have been shown to decrease time to treatment 59, [61] [62] [63] [64] and are associated with a lower mortality in one study. 65 Prehospital ECGs usually involve both the performance of the ECG in the field and its transmission to a physician for interpretation. 59, 61 By this means, rapid identification of patients with acute ST-segment elevation MI is possible, and early evidence indicates that this speeds treatment and may improve the outcome of patients with acute MI. 24, 59, 61 It is interesting that the time component that is reduced is the in-hospital time to treatment-that is, the door-to-needle time (Fig. 5) . Since the ECG is already obtained and the patient is identified as having ST-segment elevation MI, there are fewer time delays in obtaining a history or performing an ECG, for example, and in some cases thrombolytic therapy can be readied at the bedside before the patient actually arrives in the emergency department. In one randomized trial, patients whose prehospital ECG was obtained and transmitted to the emergency department had a significantly reduced door-to-needle time (30 min compared with 50 min; p = 0.004) (Fig. 5) . 63 A recent study in 66,995 patients in the multicenter National Registry of Myocardial Infarction-2 trial found that prehos- pital ECGs were associated with a 10-min decrease in doorto-needle time for thrombolysis (p < 0.001) and a 23-min decrease in door-to-balloon time for primary angioplasty (p < 0.001) (Fig. 6) . 65 In addition, patients who had a prehospital ECG performed were significantly more likely to receive reperfusion therapy, and more importantly, they had reduced mortality. Patients with a prehospital ECG had a mortality rate of 8% compared with 12% for those without a prehospital ECG. Even after correcting for differences in baseline characteristics in a multivariate model, the performance of a prehospital ECG was associated with improved survival (odds ratio 0.83, 95% confidence interval 0.71-0.96; p = 0.01). 65 This study provides evidence that the prehospital ECG is an excellent rapid marker of acute MI that helps alert health professionals to treatment options (e.g., thrombolysis). It also suggests that other tests, such as a rapid bedside troponin T measurement 66, 67 and other technologies, 34 also might assist in the early identification and management of patients with acute MI. In addition, performing the ECG early in the course of the patient evaluation and identifying ST-segment elevation can help physicians focus on acute MI rather than other diagnoses. The limitations to implementation of prehospital 12-lead ECGs are (1) proximity to the hospital (if short, then transport time will be short-less than 15 min) and (2) cell phone communication availability (in which case, the paramedics can be trained to identify ST-segment elevation and communicate the findings to the hospital). Although the benefits of prehospital ECGs are likely to be somewhat dependent on the characteristics of the healthcare system, there is strong evidence pointing to improved system performance in patients with acute MI who have prehospital ECGs. Thus, healthcare systems should consider equipping and training the EMS personnel to perform prehospital ECGs.
Prehospital Thrombolysis
Even with the introduction of field 12-lead ECGs, the development of emergency department critical pathways for acute MI, and improving hospital efficiency, door-to-needle time remains in the range of 30 min. 68 One way to further decrease the time from symptom onset to reperfusion is with prehospital initiation of thrombolytic therapy. By lysing patients in the field, some of the EMS transport time is saved in addition to eliminating door-to-needle time. Several trials of prehospital treatment with thrombolytic therapy have shown reductions in both time to treatment and mortality, especially in rural areas (Figs. 7-9) . 69, 70 The current EMS technological and logistical environments are ripe for the introduction of prehospital thrombolysis, beginning with field 12-lead ECG technology, which has proven effective and may decrease MI morbidity and mortality. 24, 61, 65 Furthermore, communication technologies, such as widespread cell phone use and 800-MHz radio coverage, have been instrumental in improving field-to-hospital communication and 12-lead ECG transmission. In addition, the recent availability of bolus thrombolytic therapy has facilitated mixing and administration in the field.
Traditionally, the use of lytics in patients going on to planned percutaneous coronary intervention has been avoided. With the advent of thrombolytic therapy that can be administered as a double-bolus dose, this tradition may begin to be relaxed since giving the first bolus dose (injection) does not commit the patient to receiving the second. An agent like reteplase, which is administered as two 10 U injections, gives flexibility in patient treatment because there is no infusion required and, if the patient does require intervention after that, the second injection does not have to be given. Data on "facilitated intervention" from the Plasminogen Activator Coronary Angioplasty Trial (PACT) suggest that thrombolytic therapy can be administered safely in patients going on to the catheterization laboratory. 71 Early results from the ongoing Strategies for Patency Enhancement in the Emergency Department (SPEED) trial, the pilot study for GUSTO IV, indicated high rates of procedural success with earlier patency achieved when the thrombolytic was started in the emergency department prior to acute percutaneous coronary intervention. 72 The Myocardial Infarction and Triage Intervention (MITI) trial compared prehospital versus hospital administration of thrombolytic therapy in the Seattle, Washington, area. 24 Patients who were treated in the prehospital phase had a significant reduction in the time to treatment with thrombolytic therapy by 33 min (p < 0.001) (Fig. 7) . 24 Although mortality was 31% lower, it was not a significant difference in this small trial. 24 However, in MITI, patients who were treated within 70 min from the onset of chest pain had a significantly lower mortality rate than those treated later: 1.2 versus 8.7% (p = 0.04).
The Grampian Region Early Anistreplase Trial (GREAT), conducted in a rural area in England, compared prehospital or "home" thrombolysis with hospital-initiated thrombolytic therapy and documented a > 2-h time saving by treatment with home thrombolysis (Fig. 8) . 69 Of importance, this 2-h savings in time to treatment was associated with a 50% reduction in mortality. At 1-year follow-up, mortality was 10.4% for patients treated at home compared with 21.6% for patients treated in the hospital (p = 0.007). 69 The European Myocardial Infarction Project was a large randomized trial of prehospital versus hospital-based thrombolytic therapy. 70 A total of 5,469 patients were randomized to either prehospital administration of anistreplase or administration of thrombolytic therapy at the hospital. Investigators achieved a 55-min reduction in the time to treatment with prehospital thrombolysis, which was associated with a strong trend toward reduction in the overall 30-day mortality: 11.1 to 9.7% (p = 0.08). 70 It is important to note that cardiovascular mortality was reduced from 9.8 to 8.3% (p = 0.05). 70 An overview of all the major prehospital thrombolysis trials is shown in Figure 9 . Prehospital treatment across all trials was associated with a 17% reduction in mortality (p = 0.03). 70 The recent consensus document of the European Society of Cardiology and the European Resuscitation Council recommends implementation of prehospital thrombolysis in any system where transport time (which includes time from ambulance arrival at the home to hospital arrival) exceeds 30 min or the aggregate of transport time and door-to-needle time in the hospital exceeds 60 min. If less time is involved, hospital-based thrombolysis is probably just as effective.
No
Prehospital Aspirin
Given the benefits of aspirin in patients with acute MI and those of rapid time to treatment with thrombolysis, it has been thought that prehospital aspirin might improve patient outcomes. However, one study found no benefit of prehospital aspirin versus administration of aspirin in the hospital. 73 A more recent report from an observational study has suggested benefit from prehospital aspirin. 74 On the other hand, overall use of aspirin is lower than what is optimal, ranging from as low as 63% in one study 36 to only 87% in others. 39, 75 Thus, standardized protocols or "checklists" that include aspirin in the prehospital phase will ensure that aspirin is not overlooked.
Additional Therapies
Although not yet studied in prehospital treatment of patients with acute MI or unstable angina, heparin is an approved drug in most interhospital advanced life support patient transfers, and future studies should address heparin's prehospital role in patients with acute MI. In addition, the availability of glycoprotein IIb/IIIa receptor inhibitors opens the door to a whole new consideration of therapies and combinations of therapies while the patient is transported to the hospital for medical treatment or primary angioplasty. Further study is ongoing and should provide further recommendations and guidelines to optimize patient treatment.
Conclusions
The field of prehospital management of patients with acute MI has expanded rapidly in the past several years. It involves the patients in their own management by trying to educate them about the importance of rapid access to 9-1-1 for evaluation in case of symptoms suggestive of acute MI. In addition, emerging evidence supports the prehospital performance of ECGs for the rapid identification of patients who will benefit from reperfusion therapy. Prehospital thrombolysis also appears to be beneficial, especially in areas where combined transport and in-hospital delays are long. Additional studies will help define the role of these strategies in a broad spectrum of prehospital emergency medical systems. For example, the current TIMI 19-ER study will address all the difficulties of implementing such a program, not in a single system setting but in 20 systems across the country. It also includes "facilitated intervention," which should provide cutting-edge data on optimizing thrombolytic therapy regimens for the best patient outcomes.
